Clinical Trial Update: Pemetrexed Plus Oxaliplatin as Adjuvant Chemotherapy for Radically Resected Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

This Clinical Trials update reports a Phase 2 study evaluating pemetrexed plus oxaliplatin as adjuvant chemotherapy after surgical resection for non-small cell …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Alimta (pemetrexed)
• Eloxatin (oxaliplatin)

Snippet

Sponsor: The First Affiliated Hospital of Guangzhou Medical University | Conditions: Non Small Cell Lung Cancer | Phase 2 | Status: UNKNOWN